XML 86 R64.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Net operating loss carry forwards $ 12,907,965 $ 12,467,570
Research and development costs 3,006,029 2,119,193
Stock compensation expense 789,373 711,598
Accrued expenses 7,330 528,148
Lease liability 389,882 512,668
Contingent liability 221,065 221,028
Acquisition liability 112,722 176,629
Bad debt and other reserves 287,900 129,924
Inventory reserves 130,605 109,176
Other temporary differences 1,049,365 203,340
Total deferred tax assets 18,902,236 17,179,274
Depreciation and amortization (5,683,259) (6,180,688)
Right of Use assets (353,763) (487,402)
Accrued expenses (424,423)
Contingent liability (38,308) (130,802)
Other temporary differences (294,608) (166,712)
Valuation allowance (12,532,298) (9,789,247)
Net deferred tax asset